251 related articles for article (PubMed ID: 8157757)
1. Lupus anticoagulant activity of some antiphospholipid antibodies against phospholipid bound beta 2 glycoprotein I.
Keeling DM; Wilson AJ; Mackie IJ; Isenberg DA; Machin SJ
J Clin Pathol; 1993 Jul; 46(7):665-7. PubMed ID: 8157757
[TBL] [Abstract][Full Text] [Related]
2. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
3. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
4. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
Galli M; Finazzi G; Bevers EM; Barbui T
Blood; 1995 Jul; 86(2):617-23. PubMed ID: 7605991
[TBL] [Abstract][Full Text] [Related]
5. Some 'antiphospholipid antibodies' bind to beta 2-glycoprotein I in the absence of phospholipid.
Keeling DM; Wilson AJ; Mackie IJ; Machin SJ; Isenberg DA
Br J Haematol; 1992 Nov; 82(3):571-4. PubMed ID: 1486037
[TBL] [Abstract][Full Text] [Related]
6. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I.
Roubey RA; Pratt CW; Buyon JP; Winfield JB
J Clin Invest; 1992 Sep; 90(3):1100-4. PubMed ID: 1522218
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface.
Pengo V; Biasiolo A; Fior MG
Thromb Haemost; 1995 Jan; 73(1):29-34. PubMed ID: 7537919
[TBL] [Abstract][Full Text] [Related]
8. "Anticardiolipin" autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding.
Roubey RA; Eisenberg RA; Harper MF; Winfield JB
J Immunol; 1995 Jan; 154(2):954-60. PubMed ID: 7814895
[TBL] [Abstract][Full Text] [Related]
9. Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects.
Vázquez-Mellado J; Llorente L; Richaud-Patin Y; Alarcón-Segovia D
J Autoimmun; 1994 Jun; 7(3):335-48. PubMed ID: 7916907
[TBL] [Abstract][Full Text] [Related]
10. Anti beta 2glycoprotein I antibodies and lupus anticoagulant in patients with recurrent pregnancy loss: prevalence and clinical significance.
Ogasawara M; Aoki K; Matsuura E; Sasa H; Yagami Y
Lupus; 1996 Dec; 5(6):587-92. PubMed ID: 9116701
[TBL] [Abstract][Full Text] [Related]
11. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
[TBL] [Abstract][Full Text] [Related]
12. Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles.
Galli M; Bevers EM; Comfurius P; Barbui T; Zwaal RF
Br J Haematol; 1993 Mar; 83(3):466-72. PubMed ID: 8485053
[TBL] [Abstract][Full Text] [Related]
13. Reactivity to beta 2 glycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis.
Forastiero RR; Martinuzzo ME; Kordich LC; Carreras LO
Thromb Haemost; 1996 May; 75(5):717-20. PubMed ID: 8725711
[TBL] [Abstract][Full Text] [Related]
14. [Antiphospholipid and anti beta 2-glycoprotein I antibodies].
Arvieux J; Roussel B; Colomb MG
Ann Biol Clin (Paris); 1994; 52(5):381-5. PubMed ID: 7856939
[TBL] [Abstract][Full Text] [Related]
15. Anti beta 2 glycoprotein I antibodies: detection and association with thrombosis.
Martinuzzo ME; Forastiero RR; Carreras LO
Br J Haematol; 1995 Feb; 89(2):397-402. PubMed ID: 7873391
[TBL] [Abstract][Full Text] [Related]
16. Lupus anticoagulant testing.
Moffat K; Raby A; Crowther M
Methods Mol Biol; 2013; 992():97-108. PubMed ID: 23546707
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of lupus anticoagulant (LA) antibodies: LA activity in dilute Russell's Viper Venom Time and dilute Kaolin Clotting Time detect different populations of antibodies in patients with the "antiphospholipid" syndrome.
Kandiah DA; Krilis SA
Thromb Haemost; 1998 Aug; 80(2):250-7. PubMed ID: 9716148
[TBL] [Abstract][Full Text] [Related]
18. Functional and binding studies of the roles of prothrombin and beta 2-glycoprotein I in the expression of lupus anticoagulant activity.
Permpikul P; Rao LV; Rapaport SI
Blood; 1994 May; 83(10):2878-92. PubMed ID: 8180383
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of antiphospholipid antibodies].
Atsumi T; Koike T
Rinsho Byori; 1998 Apr; 46(4):297-302. PubMed ID: 9594618
[TBL] [Abstract][Full Text] [Related]
20. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Alessandri C; Bombardieri M; Di Prospero L; Conigliaro P; Conti F; Labbadia G; Misasi R; Sorice M; Valesini G
Clin Exp Immunol; 2005 Apr; 140(1):173-80. PubMed ID: 15762889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
